We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $28.52, moving -3.16% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.79% for the day. Elsewhere, the Dow saw an upswing of 0.26%, while the tech-heavy Nasdaq appreciated by 1.52%.
Prior to today's trading, shares of the company had gained 28.21% outpaced the Finance sector's gain of 2.74% and the S&P 500's loss of 1.82%.
The investment community will be closely monitoring the performance of Oscar Health, Inc. in its forthcoming earnings report. It is anticipated that the company will report an EPS of $0.34, marking a 138.2% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $4.83 billion, indicating a 68.58% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $0.47 per share and a revenue of $18.7 billion, demonstrating changes of +127.81% and +59.85%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Oscar Health, Inc. is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, Oscar Health, Inc. is presently being traded at a Forward P/E ratio of 62.66. For comparison, its industry has an average Forward P/E of 9.63, which means Oscar Health, Inc. is trading at a premium to the group.
One should further note that OSCR currently holds a PEG ratio of 2.06. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The average PEG ratio for the Insurance - Multi line industry stood at 1.02 at the close of the market yesterday.
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 103, positioning it in the top 43% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $28.52, moving -3.16% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.79% for the day. Elsewhere, the Dow saw an upswing of 0.26%, while the tech-heavy Nasdaq appreciated by 1.52%.
Prior to today's trading, shares of the company had gained 28.21% outpaced the Finance sector's gain of 2.74% and the S&P 500's loss of 1.82%.
The investment community will be closely monitoring the performance of Oscar Health, Inc. in its forthcoming earnings report. It is anticipated that the company will report an EPS of $0.34, marking a 138.2% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $4.83 billion, indicating a 68.58% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $0.47 per share and a revenue of $18.7 billion, demonstrating changes of +127.81% and +59.85%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Oscar Health, Inc. is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, Oscar Health, Inc. is presently being traded at a Forward P/E ratio of 62.66. For comparison, its industry has an average Forward P/E of 9.63, which means Oscar Health, Inc. is trading at a premium to the group.
One should further note that OSCR currently holds a PEG ratio of 2.06. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The average PEG ratio for the Insurance - Multi line industry stood at 1.02 at the close of the market yesterday.
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 103, positioning it in the top 43% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.